An interventional study of Oral PCA in Prosthesis-Related Infections, sponsored by Dr. Dean Reeves Clinic. Not yet recruiting. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2025-02-05.
Sponsored by Dr. Dean Reeves Clinic · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Proof of principle pilot study of the effect of dietary nutritional loading of protocatechunic acid (PCA) on the health and welfare of individuals with prosthetic joint infection (PJI), as measured by standard biomarkers
Our purpose in the pre-surgery serial aspiration study is to determine the optimal PCA loading time duration for those with knee PJI with planned single or two stage revision.Our hypothesis, related to changes in structure and function as a result of PCA administration is that dietary nutritional loading of this nutraceutical PCA via the oral route will benefit the health and welfare of such a subject and alter the function and or structure of the human body having a PJI, as measured by improvemen in a pain biomarker, and one or more laboratory-based biomarkers.
35 studies on the registry are indexed under Prosthesis-Related Infections; 10 are open to participants now.
This study's planned enrollment of 10 is below the median of 193 across 20 interventional studies indexed under Prosthesis-Related Infections.
Browse Prosthesis-Related Infections studies →Dr. Dean Reeves Clinic is the lead sponsor of 6 studies on the registry; 3 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Dietary Supplement: Oral PCA
Administration of 1,000 mg BID of oral PCA in individuals with knee prosthetic joint infection prior to revision surgery
Change in Walking Pain 0-10 NRS
Walking pain change from time 0 to weekly follow-ups from 1-4
Time frame: 0,1, 2, 3, and 4 weeks
Change in CRP
Blood CRP change from time 0 to weekly follow-ups from 1-4
Time frame: 0,1, 2, 3, and 4 weeks
Change in ESR
Blood ESR change from time 0 to weekly follow-ups from 1-4
Time frame: 0,1, 2, 3, and 4 weeks
Change in WBC count in aspirate
Total WBC count change in periprosthetic aspirate
Time frame: 0,1, 2, 3, and 4 weeks
Bacterial colony count in aspirate
Colony count graded as 0 (No colonies), 1 (Few colonies), 2 (moderate growth) 3(heavy growth), and 4 (too numerous to count)
Time frame: 0,1, 2, 3, and 4 weeks
CXCL9
Change in Immunity Factor CXCL9 from 0 to 3 months
Time frame: 0 and 3 months
HbA1c
Change in HbA1c from 0 to 3 months
Time frame: 0 and 3 months
No study locations are listed for this record.
Start is estimated for Mar 2025; primary completion for Aug 2025, 5 months later.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Feb 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Pyrrolidonecarboxylic Acid
Prosthesis-Related Infections →
Dr. Dean Reeves Clinic